|
Real-time Estimate
Cboe BZX
16:01:06 31/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.010 USD | -1.85% |
|
-3.00% | -23.61% |
| 08-10 | Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says | MT |
| 08-10 | Morgan Stanley Adjusts Price Target on Arvinas to $10 From $11, Maintains Equalweight Rating | MT |
| Market Cap | 600M 517M 485M 443M 834M 57.37B 837M 5.75B 2.24B 28.96B 2.25B 2.2B 96.02B | P/E 2026 * |
721x | P/E 2027 * | -2.64x |
|---|---|---|---|---|---|
| Enterprise Value | 150M 129M 121M 110M 208M 14.29B 208M 1.43B 559M 7.21B 561M 549M 23.92B | EV / Sales 2026 * |
0.5x | EV / Sales 2027 * | 4.57x |
| Free-Float |
79.97% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Arvinas, Inc.
| 1 day | -1.85% | ||
| 1 week | -3.00% | ||
| Current month | +12.83% | ||
| 1 month | +12.83% | ||
| 3 months | +5.59% | ||
| 6 months | -32.19% | ||
| Current year | -23.61% |
| 1 week | 8.96 |  | 9.74 |
| 1 month | 7.92 | | 9.74 |
| Current year | 6.97 | | 14.51 |
| 1 year | 6.97 | | 14.51 |
| 3 years | 5.9 | | 53.08 |
| 5 years | 5.9 | | 98.67 |
| 10 years | 5.9 | | 108.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Randy Teel
CEO | Chief Executive Officer | 47 | 11/02/2026 |
Andrew Saik
DFI | Director of Finance/CFO | 56 | 23/06/2024 |
Angela Cacace
CTO | Chief Tech/Sci/R&D Officer | 58 | 16/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Houston
CHM | Chairman | 66 | 14/06/2023 |
Edward Kennedy
BRD | Director/Board Member | 64 | 30/06/2018 |
Briggs Morrison
CHM | Chairman | 67 | 11/02/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/05/26 | Sell | Chief Executive Officer | -2,209 | 0.0035% | ||
| 11/05/26 | Sell | Chief Financial Officer | -11,139 | 0.0174% | ||
| 11/05/26 | Sell | Chief Technology Officer | -11,108 | 0.0174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.85% | -3.00% | +14.68% | -67.88% | 600M | |
| -1.59% | -3.35% | +52.37% | +91.62% | 69.54B | |
| -2.10% | +1.41% | +44.67% | +88.55% | 64.97B | |
| -3.57% | -4.24% | +47.11% | +5.60% | 26.51B | |
| +1.70% | -4.20% | -18.26% | +442.58% | 25.89B | |
| -0.27% | -9.85% | +1.08% | -15.90% | 25.64B | |
| -0.96% | +10.36% | +283.06% | +429.04% | 20.22B | |
| -1.58% | +0.38% | +29.23% | -19.70% | 19.98B | |
| -3.36% | -7.58% | +9.47% | +535.81% | 15.69B | |
| -0.58% | -0.73% | +45.64% | +141.85% | 13.49B | |
| Average | -1.42% | -1.93% | +50.91% | +163.16% | 28.25B | |
| Weighted average by Cap. | -1.48% | -1.50% | +51.07% | +148.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 296M 255M 239M 218M 411M 28.3B 413M 2.84B 1.11B 14.29B 1.11B 1.09B 47.37B | 64.19M 55.32M 51.86M 47.34M 89.19M 6.14B 89.47M 615M 240M 3.1B 241M 236M 10.27B |
| Net income | 637K 549K 514K 470K 885K 60.85M 887K 6.1M 2.38M 30.72M 2.39M 2.34M 102M | -248M -214M -200M -183M -344M -23.69B -345M -2.38B -927M -11.96B -931M -910M -39.65B |
| Net Debt | -451M -388M -364M -332M -626M -43.08B -628M -4.32B -1.69B -21.75B -1.69B -1.66B -72.11B | -307M -264M -248M -226M -426M -29.32B -428M -2.94B -1.15B -14.8B -1.15B -1.13B -49.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/08/26 | US$9.050 | -1.42% | 74,076 |
| 28/08/26 | US$9.180 | -0.65% | 600,337 |
| 27/08/26 | US$9.240 | -0.86% | 527,006 |
| 26/08/26 | US$9.320 | -2.92% | 532,586 |
| 25/08/26 | US$9.600 | +2.78% | 530,606 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARVN Stock
Select your edition
All financial news and data tailored to specific country editions
